GLP-1 Reference Standards: Semaglutide and Tirzepatide in Metabolic Research
June 25, 2026 · by Administrator
Peptides that act on the incretin system are among the most actively studied compounds in metabolic research. Semaglutide and tirzepatide are supplied as reference standards for that laboratory work.
The incretin pathway
Incretin hormones such as GLP-1 and GIP are studied for their roles in glucose metabolism and insulin signalling. Semaglutide is a GLP-1 receptor reference standard; tirzepatide is a dual GIP/GLP-1 reference standard.
Reference materials, not products for use
We supply these strictly as research reference materials. View specifications on the Semaglutide and Tirzepatide product pages. Nothing here is a weight-loss product or advice.
Explore more
See the full Metabolic & Weight category, or read Peptides in Metabolic Research.
This article is educational and research-focused. It does not describe human use, benefits, dosing or outcomes. All products are supplied strictly for laboratory and research use only and are not for human consumption.
For research use only. Not for human consumption. This article is educational and not medical advice.